GlassScriptPhysician profile
Jennifer L Carlquist
NPI 1306038591
$54,440.91
in general payments reported to CMS, 2019-2025
31 companies · $701 in 2025
The $701 reported for 2025 was more than what 77% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $341 · 2022: $36K · 2023: $10K · 2024: $6,931 · 2025: $701.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $11K · Travel and Lodging: $3,756 · Food and Beverage: $2,956 · Long Term Medical Supply Or Device Loan: $449.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $10,500.00 |
| Travel and Lodging | $3,755.99 |
| Food and Beverage | $2,955.81 |
| Long Term Medical Supply Or Device Loan | $449.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $50,519.76 | 2021-2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $568.33 | 2022-2025 | |
| Eko Health, INC. | $449.00 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $441.83 | 2021-2025 | Farxiga, Brilinta |
| Merck Sharp & Dohme LLC | $277.83 | 2022-2025 | Verquvo, Capvaxive, Lagevrio |
| Boehringer Ingelheim Pharmaceuticals, INC. | $271.11 | 2022-2023 | Jardiance |
| Abbott Laboratories | $254.10 | 2021-2023 | Gallant |
| Esperion Therapeutics, INC. | $237.63 | 2022-2025 | Nexletol |
| Corcept Therapeutics | $231.35 | 2025 | Korlym |
| Pfizer INC. | $174.64 | 2023-2025 | |
| Philips North America LLC | $123.16 | 2022-2025 | Extended Holter, (5050) Ext Holter |
| Lilly USA, LLC | $118.34 | 2022 | |
| Janssen Pharmaceuticals, INC | $116.94 | 2022-2023 | Xarelto |
| Bayer Healthcare Pharmaceuticals INC. | $96.27 | 2022 | |
| Biosense Webster, INC. | $72.85 | 2025 | Carto 3 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alnylam Pharmaceuticals INC. | $55.94 | 2023-2025 | Amvuttra, Onpattro |
| E.R. Squibb & Sons, L.L.C. | $55.83 | 2023-2024 | Eliquis, Camzyos |
| Novo Nordisk INC | $49.45 | 2023-2024 | Ozempic, Rybelsus |
| Sanofi-Aventis U.S. LLC | $44.03 | 2022-2023 | |
| Amgen INC. | $38.85 | 2023-2025 | Repatha, Repatha |
| Abiomed | $35.87 | 2025 | |
| Genzyme Corporation | $27.88 | 2023 | |
| Medtronic, INC. | $25.45 | 2021-2023 | Adapta |
| Cardiva Medical, INC. | $24.85 | 2023 | Cardiva Vascade Mvp Vvcs 6-12f |
| Glaxosmithkline, LLC. | $23.00 | 2024 | Trelegy Ellipta |
| Itamar Medical INC | $22.77 | 2022 | |
| Cleerly, INC. | $20.65 | 2025 | Cleerly Labs, Cleerly Ischemia |
| Kestra Medical Technology Services, INC. | $17.02 | 2023 | Assure Wcd |
| Atricure, INC. | $16.64 | 2024 | |
| Biotronik INC. | $15.25 | 2024 | Biomonitor, Amvia Edge |
| W. L. Gore & Associates, INC. | $14.29 | 2025 | Gore Viabahn Vbx Balloon Expandable Endo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Carlquist listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.